Determining the Site of Origin of Malignant Arrhythmias

Primary Diagnostic Approach: Invasive EP Study

The American Heart Association recommends an invasive electrophysiology (EP) study with cardiac mapping as the definitive method to precisely localize the site of origin of malignant arrhythmias, using multielectrode catheters to record intracardiac electrical signals and identify activation sequences through programmed electrical stimulation 1, 2
The American College of Cardiology states that EP study permits precise diagnosis of the underlying arrhythmia mechanism and localization of the site of origin, involving placement of multielectrode catheters at multiple sites in the atria, ventricles, or coronary sinus 1, 2
The procedure combines intracardiac electrical signal recording from various cardiac sites to capture precise timing of electrical events and assess the location and direction of impulse propagation, programmed electrical stimulation with or without pharmacological provocation to replicate clinical arrhythmias, and activation sequence mapping requiring several recording points to determine the direction of electrical propagation 3

The European Society of Cardiology notes that sequential mapping uses multiple multipole catheters plus a roving catheter positioned in different regions of interest to measure local activation time, identifying the site of origin where activation spreads centrifugally to both atria (for atrial arrhythmias) 4
Advanced mapping technologies, such as electroanatomic 3-dimensional mapping systems and specialized multielectrode catheters, map simultaneously from multiple sites, improving speed and resolution, and providing more precise definition or localization of arrhythmia mechanism 1, 2

The American Heart Association recommends that for patients with pre-excitation (Wolff-Parkinson-White), EP study identifies high-risk features that predict life-threatening ventricular arrhythmias, including R-R interval <250 ms between two pre-excited complexes during induced atrial fibrillation, presence of multiple accessory pathways, ability to induce sustained atrioventricular reentrant tachycardia, and AVRT precipitating pre-excited atrial fibrillation 5, 6, 7
Malignant arrhythmias correlate more with the EP properties of the accessory pathway than with the presence or absence of symptoms, according to the American College of Cardiology 5, 6, 7

The European Heart Journal states that endocardial mapping traces the origin of activation to a specific area, from where it spreads centrifugally, with key characteristics including discrete P waves with clearly defined isoelectric baseline between P waves in all leads, and significant portions of cycle length without recorded activity 4
Macroreentrant mechanisms involve reentrant activation around a large central obstacle, with no single point of origin, and mapping must describe the obstacles or boundaries of the circuit, critical isthmuses that may be targets for therapeutic ablation, and atrial tissues outside the circuit activated from various parts of the circuit 4

The Journal of the American College of Cardiology recommends standard catheter placement sites, including right and left atria (via coronary sinus), His bundle, and right ventricle, and intravenous pharmacologic agents (isoproterenol, procainamide, and adenosine) are often administered to facilitate tachycardia induction, unmask conduction abnormalities, or predict drug responses 3
The American Heart Association notes that fluoroscopy has historically been the primary imaging modality, but alternative systems such as electroanatomic mapping and intracardiac echocardiography now allow SVT ablation with no or minimal fluoroscopy, with success and complication rates similar to standard techniques 1, 2